About Tectonic Therapeutic, Inc.
https://tectonictx.comTectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines.
CEO
Alise S. Reicin
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-06-21 | Reverse | 1:12 |
ETFs Holding This Stock
VTS.AX
Weight:0.00%
Shares:460.30K
IWM
Weight:0.01%
Shares:271.17K
XSU.TO
Weight:0.01%
Shares:271.17K
Summary
Showing Top 3 of 58
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
FMR LLC
Shares:2.81M
Value:$55.21M
BLACKROCK, INC.
Shares:827.85K
Value:$16.28M
BRAIDWELL LP
Shares:736.87K
Value:$14.49M
Summary
Showing Top 3 of 102
About Tectonic Therapeutic, Inc.
https://tectonictx.comTectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $21.89M ▼ | $-19.04M ▲ | 0% | $-1.02 ▲ | $-19.02M ▼ |
| Q2-2025 | $0 | $22.33M ▲ | $-19.98M ▼ | 0% | $-1.07 ▼ | $-18.65M ▼ |
| Q1-2025 | $0 | $18.3M ▲ | $-15.91M ▼ | 0% | $-0.93 ▼ | $-15.53M ▼ |
| Q4-2024 | $0 | $13.99M ▼ | $-12.37M ▲ | 0% | $-0.84 ▲ | $-11.84M ▲ |
| Q3-2024 | $0 | $19.64M | $-17.72M | 0% | $-1.2 | $-17.27M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $268.44M ▼ | $277M ▼ | $9.47M ▼ | $267.53M ▼ |
| Q2-2025 | $287.38M ▼ | $295.31M ▼ | $11.55M ▼ | $283.77M ▼ |
| Q1-2025 | $306.25M ▲ | $314.83M ▲ | $13.79M ▲ | $301.04M ▲ |
| Q4-2024 | $141.24M ▼ | $152.91M ▼ | $12.13M ▼ | $140.78M ▼ |
| Q3-2024 | $159.09M | $168.72M | $18.36M | $150.36M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-19.04M ▲ | $-17.82M ▼ | $-166K ▼ | $-457K ▲ | $-18.46M ▲ | $-18M ▼ |
| Q2-2025 | $-35.89M ▼ | $-14.72M ▼ | $55K ▲ | $-4.17M ▼ | $-18.86M ▼ | $-14.75M ▼ |
| Q1-2025 | $-15.91M ▼ | $-13.08M ▲ | $-27K ▼ | $178.12M ▲ | $165.01M ▲ | $-13.11M ▲ |
| Q4-2024 | $-12.37M ▲ | $-16.82M ▲ | $-3K ▲ | $-1.07M ▲ | $-17.86M ▲ | $-16.82M ▲ |
| Q3-2024 | $-17.72M | $-19.6M | $-153K | $-6.29M | $-26.03M | $-19.76M |
CEO
Alise S. Reicin
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-06-21 | Reverse | 1:12 |
ETFs Holding This Stock
VTS.AX
Weight:0.00%
Shares:460.30K
IWM
Weight:0.01%
Shares:271.17K
XSU.TO
Weight:0.01%
Shares:271.17K
Summary
Showing Top 3 of 58
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
FMR LLC
Shares:2.81M
Value:$55.21M
BLACKROCK, INC.
Shares:827.85K
Value:$16.28M
BRAIDWELL LP
Shares:736.87K
Value:$14.49M
Summary
Showing Top 3 of 102